- call +1-201-465-4211
- email sales@mrinsights.biz
Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along with glucose to treat high blood potassium levels. Typically it is given by injection under the skin, but some forms may also be used by injection into a vein or muscle.
Scope of the Report:
This report focuses on the Insulin Drug and Delivery Technologies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The emerging technologies in the insulin drug and delivery field have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles, leading to a steady market for these technologies. Research and development (R&D) spending, increasing competition, patent expiries and emerging technologies are guiding this to a new direction. The new advancements, new product launches, and increased awareness and early detection of the disease have influenced the market to grow in the foreseeable future.
The worldwide market for Insulin Drug and Delivery Technologies is expected to grow at a CAGR of roughly 9.2% over the next five years, will reach 55900 million US$ in 2023, from 36000 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Sanofi
Eli Lilly and Company
Biocon
Julphar
Ypsomed
Becton, Dickinson and Company
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Insulin Syringes
Insulin Vials
Insulin Pens
Insulin Pumps
Market Segment by Applications, can be divided into
Diabetes Mellitus Type 1
Diabetes Mellitus Type 2
Gestational Diabetes
There are 15 Chapters to deeply display the global Insulin Drug and Delivery Technologies market.
Chapter 1, to describe Insulin Drug and Delivery Technologies Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Insulin Drug and Delivery Technologies, with sales, revenue, and price of Insulin Drug and Delivery Technologies, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Insulin Drug and Delivery Technologies, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Insulin Drug and Delivery Technologies market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Insulin Drug and Delivery Technologies sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Insulin Drug and Delivery Technologies Introduction
1.2 Market Analysis by Type
1.2.1 Insulin Syringes
1.2.2 Insulin Vials
1.2.3 Insulin Pens
1.2.4 Insulin Pumps
1.3 Market Analysis by Applications
1.3.1 Diabetes Mellitus Type 1
1.3.2 Diabetes Mellitus Type 2
1.3.3 Gestational Diabetes
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Insulin Drug and Delivery Technologies Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly and Company
2.2.1 Business Overview
2.2.2 Insulin Drug and Delivery Technologies Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eli Lilly and Company Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biocon
2.3.1 Business Overview
2.3.2 Insulin Drug and Delivery Technologies Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biocon Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Julphar
2.4.1 Business Overview
2.4.2 Insulin Drug and Delivery Technologies Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Julphar Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Ypsomed
2.5.1 Business Overview
2.5.2 Insulin Drug and Delivery Technologies Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Ypsomed Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Becton, Dickinson and Company
2.6.1 Business Overview
2.6.2 Insulin Drug and Delivery Technologies Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Insulin Drug and Delivery Technologies Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Insulin Drug and Delivery Technologies Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Insulin Drug and Delivery Technologies Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Insulin Drug and Delivery Technologies Manufacturer Market Share in 2017
3.3.2 Top 6 Insulin Drug and Delivery Technologies Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Insulin Drug and Delivery Technologies Market Analysis by Regions
4.1 Global Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Regions
4.1.1 Global Insulin Drug and Delivery Technologies Sales and Market Share by Regions (2013-2018)
4.1.2 Global Insulin Drug and Delivery Technologies Revenue and Market Share by Regions (2013-2018)
4.2 North America Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
4.3 Europe Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
4.5 South America Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
5 North America Insulin Drug and Delivery Technologies by Countries
5.1 North America Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Countries
5.1.1 North America Insulin Drug and Delivery Technologies Sales and Market Share by Countries (2013-2018)
5.1.2 North America Insulin Drug and Delivery Technologies Revenue and Market Share by Countries (2013-2018)
5.2 United States Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
5.3 Canada Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
5.4 Mexico Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
6 Europe Insulin Drug and Delivery Technologies by Countries
6.1 Europe Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Countries
6.1.1 Europe Insulin Drug and Delivery Technologies Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Insulin Drug and Delivery Technologies Revenue and Market Share by Countries (2013-2018)
6.2 Germany Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
6.3 UK Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
6.4 France Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
6.5 Russia Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
6.6 Italy Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
7 Asia-Pacific Insulin Drug and Delivery Technologies by Countries
7.1 Asia-Pacific Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Insulin Drug and Delivery Technologies Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Insulin Drug and Delivery Technologies Revenue and Market Share by Countries (2013-2018)
7.2 China Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
7.3 Japan Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
7.4 Korea Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
7.5 India Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
8 South America Insulin Drug and Delivery Technologies by Countries
8.1 South America Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Countries
8.1.1 South America Insulin Drug and Delivery Technologies Sales and Market Share by Countries (2013-2018)
8.1.2 South America Insulin Drug and Delivery Technologies Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
8.3 Argentina Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
8.4 Colombia Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
9 Middle East and Africa Insulin Drug and Delivery Technologies by Countries
9.1 Middle East and Africa Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Insulin Drug and Delivery Technologies Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Insulin Drug and Delivery Technologies Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
9.3 UAE Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
9.4 Egypt Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
9.5 Nigeria Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
9.6 South Africa Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
10 Global Insulin Drug and Delivery Technologies Market Segment by Type
10.1 Global Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Insulin Drug and Delivery Technologies Sales and Market Share by Type (2013-2018)
10.1.2 Global Insulin Drug and Delivery Technologies Revenue and Market Share by Type (2013-2018)
10.2 Insulin Syringes Sales Growth and Price
10.2.1 Global Insulin Syringes Sales Growth (2013-2018)
10.2.2 Global Insulin Syringes Price (2013-2018)
10.3 Insulin Vials Sales Growth and Price
10.3.1 Global Insulin Vials Sales Growth (2013-2018)
10.3.2 Global Insulin Vials Price (2013-2018)
10.4 Insulin Pens Sales Growth and Price
10.4.1 Global Insulin Pens Sales Growth (2013-2018)
10.4.2 Global Insulin Pens Price (2013-2018)
10.5 Insulin Pumps Sales Growth and Price
10.5.1 Global Insulin Pumps Sales Growth (2013-2018)
10.5.2 Global Insulin Pumps Price (2013-2018)
11 Global Insulin Drug and Delivery Technologies Market Segment by Application
11.1 Global Insulin Drug and Delivery Technologies Sales Market Share by Application (2013-2018)
11.2 Diabetes Mellitus Type 1 Sales Growth (2013-2018)
11.3 Diabetes Mellitus Type 2 Sales Growth (2013-2018)
11.4 Gestational Diabetes Sales Growth (2013-2018)
12 Insulin Drug and Delivery Technologies Market Forecast (2018-2023)
12.1 Global Insulin Drug and Delivery Technologies Sales, Revenue and Growth Rate (2018-2023)
12.2 Insulin Drug and Delivery Technologies Market Forecast by Regions (2018-2023)
12.2.1 North America Insulin Drug and Delivery Technologies Market Forecast (2018-2023)
12.2.2 Europe Insulin Drug and Delivery Technologies Market Forecast (2018-2023)
12.2.3 Asia-Pacific Insulin Drug and Delivery Technologies Market Forecast (2018-2023)
12.2.4 South America Insulin Drug and Delivery Technologies Market Forecast (2018-2023)
12.2.5 Middle East and Africa Insulin Drug and Delivery Technologies Market Forecast (2018-2023)
12.3 Insulin Drug and Delivery Technologies Market Forecast by Type (2018-2023)
12.3.1 Global Insulin Drug and Delivery Technologies Sales Forecast by Type (2018-2023)
12.3.2 Global Insulin Drug and Delivery Technologies Market Share Forecast by Type (2018-2023)
12.4 Insulin Drug and Delivery Technologies Market Forecast by Application (2018-2023)
12.4.1 Global Insulin Drug and Delivery Technologies Sales Forecast by Application (2018-2023)
12.4.2 Global Insulin Drug and Delivery Technologies Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Insulin Drug and Delivery Technologies Picture
Table Product Specifications of Insulin Drug and Delivery Technologies
Figure Global Sales Market Share of Insulin Dru
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
